Clinical utility of digital technologies in Parkinson’s disease
Journal of Neural Transmission · 2026-02 · 133 (2) · 297-307
DOI: 10.1007/s00702-025-03062-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neural Transmission, online erschienen am 12.11.2025. Verfasst von Björn Falkenburger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Technische Universität Dresden, Dresden, Germany. bfalken@ukdd.de. Hauptthemen laut MEDLINE: Parkinson Disease, Digital Technology, Telemedicine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technische Universität Dresden.
Abstract (Originalsprache)
Digital health technologies (DHTs) are on the verge of changing treatment of Parkinson’s disease (PD). This narrative overview article describes DHTs that are already used or in development, focusing on technologies available in Germany and on their clinical utility. Examples include applications that are primarily used by patients, i.e., tools for patient education and empowerment, but also stand-alone interventions improving clinical outcomes including motor and non-motor symptoms. In Germany, these patient-centered DHTs fall under the HTA framework of digital health applications (DIGA). DHT for telemonitoring, in contrast, are designed to support physicians and other healthcare providers and therefore medical devices. DHT are also used increasingly as exploratory endpoints in trials testing neuroprotective treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, Technische Universität Dresden, Dresden, Germany. bfalken@ukdd.de.
- Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
- Department of Neurology, University of Hamburg, Hamburg, Germany.
- Department of Neurology, University Hospital Cologne, Cologne, Germany.
- Department of Neurology, University of Leipzig, Leipzig, Germany.
- Department of Neurology, German Center for Neurodegenerative Diseases (DZNE), LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany.
Förderung
- Technische Universität Dresden
Zitieren
APA
Falkenburger, B., Fanciulli, A., Pötter-Nerger, M., van Eimeren, T., Classen, J., Höglinger, G., Redecker, C., Winkler, J., & Klucken, J. (2026). Clinical utility of digital technologies in Parkinson’s disease. Journal of Neural Transmission, 133(2), 297-307. https://doi.org/10.1007/s00702-025-03062-3
Vancouver
Falkenburger B, Fanciulli A, Pötter-Nerger M, van Eimeren T, Classen J, Höglinger G, et al. Clinical utility of digital technologies in Parkinson’s disease. Journal of Neural Transmission. 2026;133(2):297-307. doi:10.1007/s00702-025-03062-3
BibTeX
@article{Falkenburger2026,
author = {Falkenburger, Björn and Fanciulli, Alessandra and Pötter-Nerger, Monika and van Eimeren, Thilo and Classen, Joseph and Höglinger, Günter and Redecker, Christoph and Winkler, Jürgen and Klucken, Jochen},
title = {Clinical utility of digital technologies in Parkinson’s disease},
journal = {Journal of Neural Transmission},
year = {2026},
volume = {133},
number = {2},
pages = {297--307},
doi = {10.1007/s00702-025-03062-3}
}
EUVIMED